Editorial
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. May 24, 2025; 16(5): 102456
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.102456
Unlocking early detection: How screening can save lives from cervical cancer
Chen Yin, Xiao-Bing Li
Chen Yin, Department of Oncology, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou 510000, Guangdong Province, China
Xiao-Bing Li, Department of Thoracic Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, Hubei Province, China
Author contributions: Yin C drafted manuscripts; Li XB collected, analyzed, and summarized the literature.
Supported by Natural Science Foundation of Hubei Province, No. 2019CFC929.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xiao-Bing Li, MD, PhD, Assistant Professor, Department of Thoracic Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 116 South Zhuodaoquan Road, Hongshan District, Wuhan 430079, Hubei Province, China. lixiaobing0629@126.com
Received: October 21, 2024
Revised: November 19, 2024
Accepted: March 4, 2025
Published online: May 24, 2025
Processing time: 212 Days and 23.7 Hours
Core Tip

Core Tip: The combination of human papillomavirus testing and cytological examination allows for a comprehensive assessment of cervical health, targeting high-risk individuals more effectively. By identifying both human papillomavirus infections and abnormal cell changes, this strategy ensures timely follow-up and intervention for those at increased risk of developing cervical cancer. The study’s results indicate promising detection rates for precancerous lesions, demonstrating that this integrated approach can lead to a more accurate diagnosis and ultimately save lives.